Eli Lilly & Co
LLY81
$725.72arrow_drop_down4.15%-$31.49
High Quality
S&P500
LLY81
$725.72
arrow_drop_down4.15%Performance History
| Key Stats | |
|---|---|
| Open | $747.83 |
| Prev. Close | $757.60 |
| EPS | 9.29 |
| Next Earnings Date | Jun 9, 2025 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 725.29 | 760.78 |
| 52 Week Range | 547.61 | 972.53 |
| Ratios | |
|---|---|
| EPS | 9.29 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Eli Lilly & Co (LLY)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—General
- CEO
- Mr. David A. Ricks
- Headquarters
- Indianapolis
- Employees
- 39000
- Exchange
- NYSE
Keep an eye on Eli Lilly & Co
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Eli Lilly & Co's (LLY) price per share?
The current price per share for Eli Lilly & Co (LLY) is $725.72. The stock has seen a price change of -$31.49 recently, indicating a -4.16% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Eli Lilly & Co (LLY)?
For Eli Lilly & Co (LLY), the 52-week high is $972.53, which is 34.01% from the current price. The 52-week low is $547.61, the current price is 32.52% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Eli Lilly & Co (LLY) a growth stock?
Eli Lilly & Co (LLY) has shown an average price growth of 2.66% over the past three years. It has received a score of 86 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Eli Lilly & Co as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Eli Lilly & Co (LLY) stock price performance year to date (YTD)?
As of the latest data, Eli Lilly & Co (LLY) has a year-to-date price change of -5.99%. Over the past month, the stock has experienced a price change of -5.48%. Over the last three months, the change has been -19.91%. Over the past six months, the figure is -16.2%. Looking at a longer horizon, the five-year price change stands at 415.02%.
help
Is Eli Lilly & Co (LLY) a profitable company?
Eli Lilly & Co (LLY) has a net income of $5.24B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 79.25% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 39.77% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $34.12B, with a revenue growth rate of 19.56%, providing insight into the company's sales performance and growth. The gross profit is $27.04B. Operating income is noted at $10.33B. Furthermore, the EBITDA is $16.72B.
help
What is the market capitalization of Eli Lilly & Co (LLY)?
Eli Lilly & Co (LLY) has a market capitalization of $689.73B. The average daily trading volume is 736.1, indicating the stock's liquidity and investor engagement.